Filing Details
- Accession Number:
- 0001104659-24-126395
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-06 20:02:06
- Reporting Period:
- 2024-12-04
- Accepted Time:
- 2024-12-06 20:02:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1974640 | Apogee Therapeutics Inc. | APGE | Biological Products, (No Disgnostic Substances) (2836) | 934958665 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1983476 | Carl Dambkowski | C/O Apogee Therapeutics, Inc. 221 Crescent St., Bldg. 17, Ste. 102B Waltham MA 02453 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-12-04 | 6,665 | $46.07 | 260,798 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 27, 2023.
Billionaire Hedge Funds
